Page last updated: 2024-08-26

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and Brain Vascular Disorders

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with Brain Vascular Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Löscher, W; Szabo, L; Wlaź, P1

Other Studies

1 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and Brain Vascular Disorders

ArticleYear
Focal ischemia enhances the adverse effect potential of N-methyl-D-aspartate receptor antagonists in rats.
    Neuroscience letters, 1998, Jan-02, Volume: 240, Issue:1

    Topics: Animals; Behavior, Animal; Binding, Competitive; Brain; Brain Ischemia; Cerebrovascular Disorders; Dizocilpine Maleate; Injections, Intraperitoneal; Male; Pipecolic Acids; Piperazines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate

1998